Compound 7P
Experimental compound that stimulated nerve fiber regrowth: only laboratory and rat data, not studied in humans.
The links above are labelled third-party affiliate links. MolekulaX does not sell and does not verify product quality.
Pharmacology
Contents
DETAILED OVERVIEW
What is Compound 7P?
Compound 7P is an experimental compound that was identified and developed to stimulate the regrowth of damaged nerve fibers (axons). It is not an approved medicine anywhere and not a dietary supplement; it is handled only as a laboratory research chemical.
It shifts the balance of two related signaling substances, thromboxane and prostacyclin: it blocks the first and boosts production of the second, which puts nerve cells into a state suited to growth. In cultured nerve cells it stimulated the growth of extensions, and in the damaged optic nerve of rats it set off the growth of new nerve fibers. It has not been studied in humans: there are only early, mostly laboratory data, and no human safety data. Because the two substances also affect blood platelets and blood vessels, it could in theory raise the tendency to bleed and lower blood pressure; its safety in pregnancy and breastfeeding has not been established.
Mechanism
Thromboxane block + prostacyclin shift (mTOR/STAT3)
Evidence
Preclinical only (cell + animal)
Legal status
Unapproved research chemical
No anecdote collected yet.
Receptor profile
- Neurite outgrowth / axon regeneration (mTOR, STAT3)Moderate
- Thromboxane A2 receptor / synthase (inhibition)Moderate
- Prostacyclin (PGI2) synthase selectivityWeak
Safety
Side effects, stop signs, contraindications
Side effects · 4
- No human safety data: an early-stage research compound studied only in cell and animal models
- Theoretical platelet and blood-vessel effects from shifting the prostanoid (thromboxane/prostacyclin) balance, uncharacterized in humans
- The prostacyclin shift may theoretically cause vasodilation, lower blood pressure or increased bleeding tendency
- Unknown long-term safety and an entirely missing human toxicity profile
Contraindications · 4
- Pregnancy and breastfeeding: safety not established, avoid
- People on anticoagulants or antiplatelet drugs: prostanoid modulation may theoretically increase bleeding risk
- Bleeding disorder or upcoming surgery: avoid due to theoretical platelet effects
- Not an approved drug and not a dietary supplement; experimental research chemical, not recommended without clinical supervision
Related Nootropics
Same therapeutic category
Studies
Related research and clinical findings
Discovery, Optimization, and Biological Evaluation of Sulfonamidoacetamides as an Inducer of Axon Regeneration
Ku JM, Taher M, Chin KY, et al.
Thromboxane A2 stimulates neurite outgrowth in cerebral cortical neurons via mitogen activated protein kinase signaling
Sumimoto S, et al.
FAQ
FAQ
Compound 7P is a purely experimental lab compound developed to help damaged nerve fibers (axons) regrow. In animal studies, such as rat optic-nerve injury models, it promoted nerve cell regeneration, but this is an early-stage research substance with no human experience or availability, so it shouldn't be seen as a finished product.
Telegram
Have a question about Compound 7P?
Reach out to us on Telegram for a personalized stack. We'll be happy to help.
Personalized consultation
Want a detailed conversation tailored to your data?
Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.
Fill out the form~5–7 min · prep questionnaire · confidential · GDPR-compliant
Structure & chemistry
The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.
